The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Movement Disorders - Tập 23 Số 6 - Trang 837-844 - 2008
M. A. Hely1, Wayne G.J. Reid1, Michael Adena2, Glenda M. Halliday3, John G. Morris1
1Department of Neurology, Westmead Hospital, Westmead, New South Wales, Australia
2Covance Pty Ltd, Braddon, Australian Capital Territory, Australia
3Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia

Tóm tắt

Abstract

After 20 years follow‐up of newly diagnosed patients with Parkinson's disease (PD), 100 of 136 (74%) have died. The mortality rate fell in the first 3 years of treatment, then rose compared to the general population, the standardized mortality ratio from 15 to 20 years reaching 3.1. Drug induced dyskinesia and end of dose failure were experienced by most patients, but the main current problems relate to the non‐levodopa responsive features of the disease. Dementia is present in 83% of 20‐year survivors. Dementia correlates with increasing age and probably reflects an interplay of multiple pathologies. Seventeen people with dementia had postmortems. Eight had diffuse Lewy bodies as the only cause of dementia, while others had mixed neuropathology. Only one person lives independently and 48% are in nursing homes. Excessive daytime sleepiness is noted in 70%, falls have occurred in 87%, freezing in 81%, fractures in 35%, symptomatic postural hypotension in 48%, urinary incontinence in 71%, moderate dysarthria in 81%, choking in 48%, and hallucinations in 74%. The challenge is to understand the cellular mechanisms underlying the diverse features of advanced PD that go far beyond a lack of dopamine. © 2008 Movement Disorder Society

Từ khóa


Tài liệu tham khảo

10.1002/mds.20324

10.1176/jnp.14.2.223

10.1093/brain/89.3.429

10.1002/mds.20527

10.1016/S0140-6736(84)92807-1

10.1001/archneur.60.3.387

10.1212/WNL.40.1.38

10.1212/WNL.54.8.1596

10.1007/s00415-006-0234-8

10.1002/mds.870130605

10.3109/00207458909002162

Foltynie T, 2004, The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study, Brain, 127, 1, 10.1093/brain/awh067

10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A

10.1016/j.parkreldis.2005.06.011

10.1136/jnnp.2005.083113

10.1136/jnnp.57.8.903

10.1136/jnnp.67.3.300

10.1001/archneur.1993.00540020018011

Folstein MF, 1975, “Mini‐Mental State”: a practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 182

10.1192/bjp.140.6.566

10.1212/WNL.43.11.2412-a

Kaplan E, 1983, The Boston naming test

10.1016/0022-3956(82)90033-4

10.1212/WNL.55.11.1621

10.1002/mds.1053

StataCorp 2005 Stata Statistical Software: Release 9

10.1212/01.WNL.0000148603.44618.19

10.1002/mds.21507

10.1002/mds.10633

10.1212/01.WNL.0000036610.36834.E0

10.1136/jnnp.74.9.1215

10.1136/jnnp.74.7.852

10.1212/WNL.40.1.38

10.1007/s00415-006-0234-8

10.1007/978-3-7091-6846-2_6

10.1002/mds.10295

10.1002/mds.10565

10.1212/WNL.54.10.1916

10.1002/ana.20635

10.1007/s004010100390

10.1016/S0006-8993(97)00874-3

10.1016/S0079-6123(03)45020-6

10.1001/archneur.60.12.1745

10.1002/mds.20700

10.1212/01.wnl.0000184517.69816.e9